UPBUpstream Bio, Inc.vs its industry peers
A metric-by-metric comparison of Upstream Bio, Inc. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UPB본 종목 | $291M#7 | — | 1.1x#3 | 101.9x#9 | 20.4%#4 | -128.4%#12 | -5618.8%#10 | -52.9%#8 | — | — | -69.2%#15 | — |
| CATX | $332M#1 | — | 1.0x#2 | 231.6x#10 | — | -30.1%#9 | -7919.4%#11 | -31.8%#6 | -41.0%#1 | — | -11.6%#11 | — |
| QTTB | $320M#4 | 3.4x#1 | 3.0x#10 | 6.0x#3 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | 517.5%#1 | — |
| ABEO | $322M#2 | — | 2.5x#9 | 55.3x#7 | — | -211.7%#13 | -1536.9%#9 | -55.6%#9 | -121.6%#2 | — | -0.2%#10 | — |
| CTNM | $320M#3 | — | 1.3x#7 | — | -100.0%#10 | -41.9%#10 | — | -25.0%#4 | — | — | 11.8%#9 | — |
| VNDA | $306M#5 | — | 1.4x#8 | 1.4x#1 | 8.7%#5 | -1066.7%#16 | -70.0%#3 | -100.1%#11 | — | — | 11.9%#8 | — |
| SION | $297M#6 | — | 1.1x#5 | — | — | -22.0%#7 | — | -28.3%#5 | — | — | -71.6%#16 | — |
| CUE | $272M#11 | — | 117.6x#14 | 9.9x#4 | 195.7%#2 | 34.6%#2 | -96.7%#4 | -1151.6%#15 | — | — | 69.2%#3 | — |
| FULC | $288M#8 | — | 0.9x#1 | — | -100.0%#10 | -670.0%#15 | — | -24.1%#3 | — | — | -49.9%#14 | — |
| PYXS | $282M#9 | — | 24.7x#12 | 20.4x#6 | -14.2%#7 | -3.0%#4 | -609.2%#6 | -696.0%#14 | — | — | 46.5%#6 | — |
| GLSI | $275M#10 | — | 88.4x#13 | — | — | -11.2%#5 | — | -621.1%#13 | — | — | 62.9%#4 | — |
| TRDA | $258M#14 | — | 1.1x#4 | 10.1x#5 | -87.9%#9 | -319.0%#14 | -621.1%#7 | -61.6%#10 | — | — | 19.2%#7 | — |
| MGNX | $265M#12 | — | 6.2x#11 | 1.8x#2 | -0.3%#6 | -11.4%#6 | -48.7%#2 | -0.2%#2 | — | — | 141.2%#2 | — |
| LYEL | $263M#13 | — | 1.1x#6 | 7293.7x#11 | -41.0%#8 | 20.0%#3 | -748344.4%#12 | -117.4%#12 | — | — | -14.6%#12 | — |
| BCYC | — | — | — | — | 105.8%#3 | -29.5%#8 | -340.4%#5 | -42.9%#7 | -794.1%#3 | — | -48.3%#13 | — |
| CAMP | $253M#15 | — | — | 72.2x#8 | 436.5%#1 | -55.2%#11 | -1502.4%#8 | — | — | — | 60.0%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice